Sponsors

Lead Sponsor

Columbia University

Collaborators

Children's Hospital of Philadelphia
American Academy of Pediatrics
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)

The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first season. Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages. Within each practice site, parents of eligible children will be randomized to receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2) COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care). Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.

Related studies

RECRUITING

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

NCT01386424 · Zika, Influenza

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

NCT07169318 · Influenza

RECRUITINGPhase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213 · Adenovirus Infection, BK Virus Infection, and more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

View all related studies →

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Trial snapshot

Condition

Locations shown

For caregivers